These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 33317721)

  • 1. Serum homocysteine level is an independent predictor for hemorrhagic transformation within 24 h of intravenous thrombolysis in acute ischemic stroke.
    Liu L; Teng J; Ma M; Guo L; Yang L; Gao J; Du Y
    J Clin Neurosci; 2020 Dec; 82(Pt A):13-19. PubMed ID: 33317721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. U-Shaped Association Between Serum Uric Acid and Hemorrhagic Transformation After Intravenous Thrombolysis.
    Cheng Z; Zhan Z; Fu Y; Zhang WY; Xia L; Xu T; Chen H; Han Z
    Curr Neurovasc Res; 2022; 19(2):150-159. PubMed ID: 35796447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intravenous thrombolysis in acute ischemic stroke patients with cerebral microbleeds and analysis of risk factors for hemorrhagic transformation.
    Lei YS; Li H; Lei JY; Li SX; Li DF
    Eur Rev Med Pharmacol Sci; 2022 Feb; 26(3):779-786. PubMed ID: 35179744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive Role of Pre-Thrombolytic Neutrophil-Platelet Ratio on Hemorrhagic Transformation After Intravenous Thrombolysis in Acute Ischemic Stroke.
    Cheng XD; Zhang CX; Zhang Q; Zhou S; Jia LJ; Wang LR; Wang JH; Yu NW; Li BH
    Clin Appl Thromb Hemost; 2024; 30():10760296231223192. PubMed ID: 38166411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nomogram to Predict Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis in Acute Ischemic Stroke in Asian Population.
    Xie X; Yang J; Ren L; Hu S; Lian W; Xiao J; Pan L; Deng L; Ma J
    Curr Neurovasc Res; 2021; 18(5):543-551. PubMed ID: 34951382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circadian Rhythm and Risk of Hemorrhagic Transformation after Acute Ischemic Stroke Treated with Intravenous Thrombolysis - A Systematic Review.
    Stan A; Dragos H; Strilciuc S; Ilut S; Vacaras V; Cozma A; Panaitescu PS; Stan H; Muresanu DF
    CNS Neurol Disord Drug Targets; 2023; 22(10):1493-1506. PubMed ID: 36200200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal Dysfunction Associated with Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis.
    Zhu J; Shen X; Han C; Mei C; Zhou Y; Wang H; Kong Y; Jiang Y; Fang Q; Cai X
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104363. PubMed ID: 31501038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Non-Traditional Lipid Parameters with Hemorrhagic Transformation and Clinical Outcome After Thrombolysis in Ischemic Stroke Patients.
    Luo Y; Chen J; Yan XL; Jin H; Sun X; Guo ZN; Yang Y
    Curr Neurovasc Res; 2020; 17(5):736-744. PubMed ID: 33397260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Taking Warfarin with Subtherapeutic INR.
    Mowla A; Memon A; Razavi SM; Lail NS; Vaughn CB; Mohammadi P; Sawyer RN; Shirani P
    J Stroke Cerebrovasc Dis; 2021 May; 30(5):105678. PubMed ID: 33640783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Admission Leukocyte Count with Clinical Outcomes in Acute Ischemic Stroke Patients Undergoing Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator.
    Chen J; Zhang FL; Lv S; Jin H; Luo Y; Qu Y; Guo ZN; Yang Y
    Curr Neurovasc Res; 2020; 17(5):660-666. PubMed ID: 33243121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of in-hospital mortality and the risk of symptomatic intracerebral hemorrhage after thrombolytic therapy with recombinant tissue plasminogen activator in acute ischemic stroke.
    Al-Khaled M; Matthis C; Eggers J
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):7-11. PubMed ID: 22578915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex difference in the association between triglyceride and intracerebral bleeding risk after intravenous thrombolysis for acute ischemic stroke, a multi-center retrospective study.
    Yuan Q; Han Y; Fang S; Lei H; Huang H; Lin H; Wu X; Chen R; Chen Z; Chen J; Li H; Liu N; Du H
    PeerJ; 2024; 12():e17558. PubMed ID: 38938613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory factors associated with symptomatic hemorrhagic conversion of acute stroke after systemic thrombolysis.
    Kamal H; Mehta BK; Ahmed MK; Kavak KS; Zha A; Lail NS; Shirani P; Al-Mufti F; Sawyer RN; Mowla A
    J Neurol Sci; 2021 Jan; 420():117265. PubMed ID: 33333324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral Microbleeds are an Independent Predictor of Hemorrhagic Transformation Following Intravenous Alteplase Administration in Acute Ischemic Stroke.
    Nagaraja N; Tasneem N; Shaban A; Dandapat S; Ahmed U; Policeni B; Olalde H; Shim H; Samaniego EA; Pieper C; Ortega-Gutierrez S; Leira EC; Adams HP
    J Stroke Cerebrovasc Dis; 2018 May; 27(5):1403-1411. PubMed ID: 29398533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low Serum Albumin level as a Predictor of Hemorrhage Transformation after Intravenous Thrombolysis in Ischemic Stroke Patients.
    Che R; Huang X; Zhao W; Jiang F; Wu L; Zhang Z; Bian T; Ma Q; Yu Z; Zhang Q; Dong K; Song H; Ji X
    Sci Rep; 2017 Aug; 7(1):7776. PubMed ID: 28798356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Risk of Hemorrhagic Transformation After Thrombolysis for Acute Ischemic Stroke in Chinese Versus North Americans: A Comparative Study.
    Xu X; Wang D; Wang F; Norton C; Liu X; Selim M
    J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2381-2387. PubMed ID: 29778315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombocytopenia and In-hospital outcomes in patients with acute ischemic stroke undergoing intravenous thrombolysis: Findings from a nationwide registry study in China.
    Xu Y; Liu C; Zhou Q; Gu H; Jia Y; Meng D; Wang J; Li W; Liu J; Li Z; Yang X; Guo L
    J Stroke Cerebrovasc Dis; 2024 Aug; 33(8):107805. PubMed ID: 38839025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iodinated Contrast Agents Reduce the Efficacy of Intravenous Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke Patients: a Multicenter Cohort Study.
    Chen Z; Xu C; Zhong W; Gong X; Hu H; Zhang X; Chen Y; Li Q; Luo Z; Chen Z; Lou M
    Transl Stroke Res; 2021 Aug; 12(4):530-539. PubMed ID: 32895894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis in Acute Ischemic Stroke: The Symptomatic Intracranial Hemorrhage Score.
    Lokeskrawee T; Muengtaweepongsa S; Patumanond J; Tiamkao S; Thamangraksat T; Phankhian P; Pleumpanupat P; Sribussara P; Kitjavijit T; Supap A; Rattanaphibool W; Prisiri J
    J Stroke Cerebrovasc Dis; 2017 Nov; 26(11):2622-2629. PubMed ID: 28826584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new nomogram for individualized prediction of the probability of hemorrhagic transformation after intravenous thrombolysis for ischemic stroke patients.
    Wu Y; Chen H; Liu X; Cai X; Kong Y; Wang H; Zhou Y; Zhu J; Zhang L; Fang Q; Li T
    BMC Neurol; 2020 Nov; 20(1):426. PubMed ID: 33234113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.